Evidence map›Paper›PMID 33308246›Full record

Observational studyHealth and quality of life outcomes2020

Health-related quality of life in nonvalvular atrial fibrillation patients with controlled or uncontrolled anticoagulation status.

José Felipe Varona, José Miguel Seguí-Ripoll, Cristina Lozano-Duran, Luis Miguel Cuadrado-Gómez, Juan Bautista Montagud-Moncho, Antonio Ramos-Guerrero, José Carlos Mirete-Ferrer, Esther Donado, Javier García-Alegría, REQUOL Study Group

Erratum issuedOpen access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Health and quality of life outcomes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

José Felipe VaronaHospital HM Montepríncipe, Boadilla del Monte, Madrid, Spain.
José Miguel Seguí-RipollHospital San Juan de Alicante, San Juan de Alicante, Alicante, Spain.
Cristina Lozano-DuranHospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.
Luis Miguel Cuadrado-GómezHospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.
Juan Bautista Montagud-MonchoHospital Francesc de Borja, Gandía, Valencia, Spain.
Antonio Ramos-GuerreroHospital San Juan de Dios del Aljarafe, Bormujos, Seville, Spain.
José Carlos Mirete-FerrerHospital de Torrevieja, Torrevieja, Alicante, Spain.
Esther DonadoBoehringer-Ingelheim, Sant Cugat del Vallés, Barcelona, Spain.
Javier García-AlegríaHospital Costa del Sol, A-7, Km 187, 29603, Marbella, Malaga, Spain. jg.alegria@hotmail.com.
REQUOL Study Group
Hospital Universitario Príncipe de Asturias · ESBoehringer Ingelheim (Spain) · ESHospital Costa del Sol · ESHospital Quirón Torrevieja · ESHospital Universitario HM Madrid · ESUniversitat de Miguel Hernández d'Elx · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is a dearth of evidence regarding Health-Related Quality of Life (HRQoL) in nonvalvular atrial fibrillation (NVAF) patients undergoing oral anticoagulation therapy. Our objective was to describe HRQoL in NVAF patients on oral anticoagulation, focusing on uncontrolled patients on vitamin K antagonists (VKAs) versus controlled patients on VKAs or non-vitamin K antagonist oral anticoagulants (NOACs), in a real-world setting. Additionally, we assessed the clinical characteristics of patients with uncontrolled anticoagulation.

methodsAn observational, multicentre, and cross-sectional study, enrolling 38 Spanish Hospitals' Internal Medicine Departments. HRQoL was assessed using the validated Spanish version of the Sawicki questionnaire. High self-perceived HRQoL was indicated by high scores in the general treatment satisfaction and self-efficacy dimensions, and by low scores in the strained social network, daily hassles and distress dimensions.

resultsFive hundred and one patients were included for assessment. Mean scores ± SD were closer to a high perceived HRQoL in controlled than uncontrolled patients for the five dimensions of the questionnaire: 4.9 ± 1.0 versus 3.6 ± 1.3 for general treatment satisfaction; 4.3 ± 1.0 versus 3.6 ± 1.0 for self-efficacy, 3.1 ± 0.9 versus 3.9 ± 1.1 for strained social network, 2.1 ± 0.8 versus 3.0 ± 1.0 for daily hassles and 1.8 ± 0.9 versus 2.6 ± 1.2 for distress.

conclusionsHRQoL in patients with controlled anticoagulant status treated with NOACs or VKAs was better than in patients with uncontrolled anticoagulant status. This seems to indicate that anticoagulation control status influences perception of HRQoL, highlighting the importance of its evaluation when assessing HRQoL in NVAF patients.

Indexed as

Quality of LifeAdministration, OralAdultAgedAged, 80 and overAnticoagulantsAtrial FibrillationCase-Control StudiesCross-Sectional StudiesFemaleHumansMaleMiddle AgedPatient SatisfactionSurveys and QuestionnairesVitamin KAnticoagulantsVitamin KAnticoagulation controlHealth-related quality of lifeNonvalvular atrial fibrillationNon-vitamin K antagonist oral anticoagulantsVitamin K antagonists

Identifiers

PMID33308246
PMCPMC7731734
OpenAlexW3111447011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.